Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Balch, C. M.
Right arrow Articles by Mihm, M. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balch, C. M.
Right arrow Articles by Mihm, M. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 13:175-176, 2002
© 2002 European Society for Medical Oncology

Letters to the Editor

Reply to the article "The AJCC staging proposal for cutaneous melanoma: comments by the EORTC Melanoma Group", by D. J. Ruiter et al. (Ann Oncol 2001; 12: 9–11)

C. M. Balch1 and M. C. Mihm2

1Chairman, AJCC Melanoma Staging Committee, Departments of Surgery and Oncology, Johns Hopkins Medical Institutions, Baltimore, MD; 2Member, AJCC Melanoma Staging Committee, Clinical Professor of Pathology, Harvard Medical School/Massachusetts General Hospital, Co Chairman, Pathology Committee, WHO Melanoma Program, USA

The EORTC Melanoma Group has written a thorough analysis of the proposed melanoma staging system published previously by the Melanoma Staging Committee of the American Joint Committee on Cancer (AJCC) [1]. The EORTC Melanoma Group leadership have also provided helpful input, some of which contributed to the final revisions of the staging criteria. To validate the accuracy of this proposed staging system, 13 cancer centers and cancer cooperative groups contributed staging and survival data from 17 600 melanoma patients from the United States, Europe and Australia [2]. This analysis, along with advice from melanoma experts, has resulted in a final version which has been formally approved by . . . [Full Text of this Article]

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?